| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/23/2000 | EP0980204A1 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES |
| 02/23/2000 | EP0980202A1 Methods for viral inactivation and compositions for use in same |
| 02/23/2000 | EP0792188B1 Method of and apparatus for drying blood plasma |
| 02/23/2000 | EP0684864A4 Methods for characterizing complex filtration media |
| 02/23/2000 | CN1245433A Extract of pine needle and use thereof |
| 02/23/2000 | CN1245432A Absorbable composition containing propionic bacteria capable of releasing nitric oxide in human or animal alimentary canal |
| 02/23/2000 | CN1245399A Method of biological control |
| 02/23/2000 | CN1245398A Method of biological control |
| 02/23/2000 | CN1245067A Medicine for conditioning intestine and treating diarrhea |
| 02/23/2000 | CN1245061A Medical wine for late esophagus cancer and its preparing process |
| 02/23/2000 | CN1049683C Panjijiu-medicinal wine and its preparing process |
| 02/23/2000 | CN1049599C Medicine for treatment of thromboangiitis obliterans |
| 02/23/2000 | CN1049598C Chinese medicine prepn. for psoriasis and its prepn. process |
| 02/23/2000 | CN1049597C Liquid medicine for treatment of tracheitis and preparing method thereof |
| 02/23/2000 | CN1049596C Medicine composition for curing arthritis |
| 02/23/2000 | CN1049595C Hematopoietic table and producing process thereof |
| 02/23/2000 | CN1049590C 全蝎擦剂 Scorpion liniment |
| 02/23/2000 | CN1049589C Vulneary for promoting healing of wound |
| 02/23/2000 | CN1049588C Medicine for curing sleepless |
| 02/23/2000 | CN1049585C Medicine for treatment of lumbar intervertebral disc protrusion |
| 02/23/2000 | CN1049583C Chinese medicine stomach ultrasonophy B developer and preparing process thereof |
| 02/23/2000 | CN1049582C Chinese medicine pill for treating chronic senile bronchitis |
| 02/23/2000 | CN1049579C Method for preparing bear gall wine |
| 02/22/2000 | US6028118 Mammalian skin barrier |
| 02/22/2000 | US6028060 Treatment of chronic inflammatory diseases with CM101/GBS toxin |
| 02/22/2000 | US6027921 Chimeric proteins for use in transport of a selected substance into cells and DNA encoding chimeric proteins |
| 02/22/2000 | US6027734 To provide protection against pneumococcal colonization and systemic infection, intranasally administering a composition consisting essentially of pneumococcal surface protein a or a fragment containing a protection-eliciting epitope |
| 02/22/2000 | US6027728 A selection of herbal powder for application to human skin to remove one layer and accelerate replacement; eczema; psoriasis; skin disorders; antiiflammatory agents; antiallergens |
| 02/22/2000 | US6027657 Systems and methods for collecting diluted mononuclear cells |
| 02/22/2000 | US6027441 Systems and methods providing a liquid-primed, single flow access chamber |
| 02/22/2000 | CA2003455C Immunotherapy involving cd28 stimulation |
| 02/17/2000 | WO2000008194A2 Cell lines for the propagation of mutated herpes viruses |
| 02/17/2000 | WO2000008193A2 Latency-active regulatory sequences of herpesviruses and latency-inactive herpesvirus for gene transfer |
| 02/17/2000 | WO2000008192A2 Herpesviral vectors for gene delivery |
| 02/17/2000 | WO2000008191A2 Herpes virus vectors for dendritic cells |
| 02/17/2000 | WO2000008171A1 N-acetylglycosaminyl transferase genes |
| 02/17/2000 | WO2000008166A1 Recombinant poliovirus for the treatment of cancer |
| 02/17/2000 | WO2000008147A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 02/17/2000 | WO2000008144A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 02/17/2000 | WO2000008133A1 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE |
| 02/17/2000 | WO2000008130A2 Method for preparing a cartilage cell suspension |
| 02/17/2000 | WO2000008053A1 Novel g-protein coupled receptor protein and dna thereof |
| 02/17/2000 | WO2000008051A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/17/2000 | WO2000007659A1 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| 02/17/2000 | WO2000007631A1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 02/17/2000 | WO2000007618A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 02/17/2000 | WO2000007606A2 Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria |
| 02/17/2000 | WO2000007571A2 Formulations having probiotically active microorganisms |
| 02/17/2000 | WO2000007557A1 Cosmetic and dermatological preparations comprising an effective content of bile acids, their salts and/or their derivatives |
| 02/17/2000 | WO1999063101A3 Transfected cells and methods for treating diabetes |
| 02/17/2000 | WO1993014791A3 Method of inactivation of viral and bacterial blood contaminants |
| 02/17/2000 | DE19831768A1 Vorrichtung zur Bestrahlung einer Flüssigkeit Apparatus for irradiating a liquid |
| 02/17/2000 | CA2346123A1 Recombinant poliovirus for the treatment of cancer |
| 02/17/2000 | CA2339643A1 Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria |
| 02/17/2000 | CA2339352A1 N-acetylglycosaminyltransferase genes |
| 02/17/2000 | CA2339347A1 Novel g protein-coupled receptor cdna sequence |
| 02/17/2000 | CA2339322A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 02/17/2000 | CA2338382A1 Herpesviral vectors for gene delivery |
| 02/17/2000 | CA2337963A1 Latency-active regulatory sequences of herpesviruses and latency-inactive herpesvirus for gene transfer |
| 02/17/2000 | CA2336592A1 Cell lines for the propagation of mutated herpes viruses |
| 02/17/2000 | CA2336523A1 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/17/2000 | CA2335648A1 A novel g protein-coupled receptor protein and its dna |
| 02/16/2000 | EP0979292A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
| 02/16/2000 | EP0979290A2 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors |
| 02/16/2000 | EP0979284A2 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 02/16/2000 | EP0979101A1 Recombinant canine adenovirus (cav) containing exogenous dna |
| 02/16/2000 | EP0979093A1 Arrestable therapeutic viral agent |
| 02/16/2000 | EP0784605B1 Selective process for the deacylation of acylated compounds |
| 02/16/2000 | CN1244772A Targeted cytotoxic cell |
| 02/16/2000 | CN1244426A Fast-acting nemostatic pellet |
| 02/16/2000 | CN1244411A Tiandihua liquid for promoting hemopoiesis |
| 02/16/2000 | CN1244409A Chinese medicine for hepatitis B and its preparation |
| 02/16/2000 | CN1244404A Rheumatoid disease eliminating pellet |
| 02/16/2000 | CN1244397A Diabetes treating medicine |
| 02/16/2000 | CN1244396A Preparation of bufonin capsule |
| 02/16/2000 | CN1244395A Externally-used burn and scald treating Chinese medicine ointment and its preparation |
| 02/16/2000 | CN1049353C Chinese medicinal preparation for curing rheumatism and rheumatoid disease and its preparing method |
| 02/16/2000 | CN1049347C Processing method for 'Huangpeijing' |
| 02/16/2000 | CN1049344C Nutrient health-care oral liquor containing bee larva nutritive composition |
| 02/16/2000 | CN1049340C Medicine for curing mastosis |
| 02/16/2000 | CN1049339C Chinese drug for anti-cancer and its preparing method |
| 02/16/2000 | CN1049338C Medicine liquid for curing hepatitis B |
| 02/15/2000 | US6025474 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 02/15/2000 | US6025340 Surface expression of enzyme in gene directed prodrug therapy |
| 02/15/2000 | US6025334 Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof |
| 02/15/2000 | US6024984 Composition containing an extract from muirapuama root and plant worm extract |
| 02/15/2000 | US6024965 Immunology for treatment of aids and t-cell epitopes |
| 02/15/2000 | US6024961 Recombinant avirulent immunogenic S typhi having rpos positive phenotype |
| 02/10/2000 | WO2000006764A1 Gastrointestinal bacterial antibody factories |
| 02/10/2000 | WO2000006758A1 Self-deleting vectors for cancer therapy |
| 02/10/2000 | WO2000006705A2 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 02/10/2000 | WO2000006704A2 Hematopoietic cell composition for use in transplantation |
| 02/10/2000 | WO2000006703A2 Inhibition of graft versus host disease |
| 02/10/2000 | WO2000006702A1 Cancer cells from body fluids containing cells, isolation thereof and agents containing the same |
| 02/10/2000 | WO2000006701A1 Improvement of cardiac function by mesenchymal stem cell transplantation |
| 02/10/2000 | WO2000006700A1 Production and use of dopaminergic cells to treat dopaminergic deficiencies |
| 02/10/2000 | WO2000006605A2 Heterominibodies |
| 02/10/2000 | WO2000006601A1 Isoforms of human calcium sensing receptor |
| 02/10/2000 | WO2000006598A1 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 02/10/2000 | WO2000006205A1 Regulated expression of recombinant proteins using rna viruses |